Rocket Pharmaceuticals (RCKT) Goodwill (2018 - 2026)

Rocket Pharmaceuticals (RCKT) has 9 years of Goodwill data on file, last reported at $39.2 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill changed 0.12% year-over-year to $39.2 million; the trailing twelve-month figure through Mar 2026 stood at $39.2 million (changed 0.12% YoY), and the FY2025 full-year result was $39.2 million, changed 0.0% from the prior year.
• Goodwill was little changed at $39.2 million in Q1 2026, from $39.2 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $39.2 million in Q4 2022 to a low of $30.8 million in Q1 2022.
• A 5-year average of $37.7 million and a median of $39.2 million in 2023 frame the typical range for Goodwill.
• Across the five-year window, Goodwill advanced 27.21% in 2022 and declined 0.12% in 2026, its largest moves.
• Tracing RCKT's Goodwill over 5 years: stood at $39.2 million in 2022, then changed by 0.0% to $39.2 million in 2023, then changed by 0.0% to $39.2 million in 2024, then changed by 0.0% to $39.2 million in 2025, then slipped by 0.12% to $39.2 million in 2026.
• Business Quant data shows RCKT's Goodwill at $39.2 million in Q1 2026, $39.2 million in Q4 2025, and $39.2 million in Q3 2025.